01 1 Talion
02 3Talion
Main Therapeutic Indication : Others
Currency : USD
2014 Revenue in Millions : 17%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-allergic
Currency : USD
2017 Revenue in Millions : 181
2016 Revenue in Millions : 177
Growth (%) : 3
Main Therapeutic Indication : Anti-Allergic
Currency : USD
2018 Revenue in Millions : 73
2017 Revenue in Millions : 170
Growth (%) : -57%
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 51
2018 Revenue in Millions : 75
Growth (%) : -32
